NASDAQ (usa) | 6715.56 | -12.11 | -0.18% | |
FTSE 100 (london) | 7487.96 | -5.12 | -0.07% | |
DAX (german) | 13465.51 | 235.94 | 1.78% | |
NIKKEI 225 (japan) | 22420.08 | 408.47 | 1.86% | |
Hang - Seng (hong kong) | 28594.06 | 348.52 | 1.23% |
NIFTY - 50 (india) | ||||
Straits Times (singapore) | 3391.61 | 17.53 | 0.52% | |
KOSPI (korea) | 2556.47 | 33.04 | 1.31% | |
All Ordinaries (australia) | 6005.30 | 28.90 | 0.48% | |
BOVESPA (brazil) | 74092.76 | -215.73 | -0.29% |
GenSight Biologics S.A. (LSE: 0RIM)
0RIM Technical Analysis
5
As on 13th Nov 2024 0RIM STOCK Price closed @ 0.35 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 0.55 & Strong Sell for SHORT-TERM with Stoploss of 0.78 we also expect STOCK to react on Following IMPORTANT LEVELS. |
0RIMSTOCK Price
Open | 0.33 | Change | Price | % |
High | 0.37 | 1 Day | 0.04 | 12.90 |
Low | 0.33 | 1 Week | 0.02 | 6.06 |
Close | 0.35 | 1 Month | -0.01 | -2.78 |
Volume | 27274 | 1 Year | -0.53 | -60.23 |
52 Week High 0.96 | 52 Week Low 0.29 |
LSE UK Most Active Stocks
NTOG | 0.02 | -50.00% |
TRP | 0.03 | 0.00% |
VELA | 0.01 | % |
MSMN | 0.04 | 0.00% |
UKOG | 0.02 | 0.00% |
RRR | 0.04 | 0.00% |
DKE | 0.15 | 0.00% |
NNN | 0.09 | 50.00% |
DMTR | 0.03 | 0.00% |
BOIL | 0.08 | 0.00% |
LSE UK Top Gainers Stocks
LSE UK Top Losers Stocks
0RIM Daily Charts |
0RIM Intraday Charts |
Whats New @ Bazaartrend |
0RIM Free Analysis |
|
0RIM Important Levels Intraday
RESISTANCE | 0.43 |
RESISTANCE | 0.40 |
RESISTANCE | 0.39 |
RESISTANCE | 0.37 |
SUPPORT | 0.33 |
SUPPORT | 0.31 |
SUPPORT | 0.30 |
SUPPORT | 0.27 |
0RIM Forecast November 2024
4th UP Forecast | 0.99 |
3rd UP Forecast | 0.78 |
2nd UP Forecast | 0.66 |
1st UP Forecast | 0.53 |
1st DOWN Forecast | 0.17 |
2nd DOWN Forecast | 0.04 |
3rd DOWN Forecast | -0.08 |
4th DOWN Forecast | -0.29 |
0RIM Weekly Forecast
4th UP Forecast | 0.66 |
3rd UP Forecast | 0.56 |
2nd UP Forecast | 0.50 |
1st UP Forecast | 0.44 |
1st DOWN Forecast | 0.26 |
2nd DOWN Forecast | 0.20 |
3rd DOWN Forecast | 0.14 |
4th DOWN Forecast | 0.04 |
0RIM Forecast2024
4th UP Forecast | 1.8 |
3rd UP Forecast | 1.33 |
2nd UP Forecast | 1.05 |
1st UP Forecast | 0.76 |
1st DOWN Forecast | -0.06 |
2nd DOWN Forecast | -0.35 |
3rd DOWN Forecast | -0.63 |
4th DOWN Forecast | -1.1 |
GenSight Biologics S.A. ( LSE UK Symbol : 0RIM )
Sector : N/A And Other Stocks in Same Sector
Sector : N/A And Other Stocks in Same Sector
0RIM Other Details
Segment | EQ | |
Market Capital | 197445776.00 | |
Sector | ||
Industry | ||
Offical website | > echo $website ; ?> |
0RIM Address
0RIM Latest News
0RIM Business Profile
GenSight Biologics S.A., a clinical-stage biotechnology company, engages in the discovery, development, and commercialization of therapies for mitochondrial and neurodegenerative diseases of the eye and central nervous system. The company develops its products through gene therapy-based mitochondrial targeting sequence and optogenetics technology platforms. Its lead product candidates include LUMEVOQ, a recombinant AAV2-based gene therapy, which is in Phase III clinical trials for the treatment of leber hereditary optic neuropathy caused by a mutated ND4 gene; and GS030, which is in Phase III clinical trial for the treatment of retinitis pigmentosa, as well as in Phase I/II clinical trial to treat dry age-related macular degeneration. The company also develops products that are in preclinical stage targeting ophthalmic and neurodegenerative diseases. GenSight Biologics S.A. was incorporated in 2012 and is headquartered in Paris, France. Address: 74, rue du Faubourg Saint-Antoine, Paris, France, 75012
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service